Nanoparticles based on a hydrophilic polyester with a sheddable peg coating for protein delivery

Pharmaceutical Research

Volumn 31, Issue 10, 2014, Pages 2593-2604

  Samadi, Neda ^a   Van Steenbergen, Mies J ^a   Van Den Dikkenberg, Joep B ^a   Vermonden, Tina ^a   Van Nostrum, Cornelus F ^a   Amidi, Maryam ^a   Hennink, Wim E ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

biodegradable; nanoparticles; polyethylene glycol (PEG); protein release; shedding

Indexed keywords

BOVINE SERUM ALBUMIN; DRUG CARRIER; LYSOZYME; MACROGOL DERIVATIVE; NANOPARTICLE; POLY(LACTIC-CO-GLYCOLIC-CO-HYDROXYMETHYLGLYCOLIC ACID); POLYESTER; POLYETHYLENE GLYCOL-BLOCK-POLY(LACTIC-CO-GLYCOLIC-CO-HYDROXYMETHYLGLYCOLIC ACID);

CHEMICAL PHENOMENA; CHEMISTRY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; PARTICLE SIZE; SURFACE PROPERTY; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

DRUG CARRIERS; DRUG COMPOUNDING; DRUG LIBERATION; DRUG STABILITY; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROSCOPY, ELECTRON, TRANSMISSION; MURAMIDASE; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; SERUM ALBUMIN, BOVINE; SURFACE PROPERTIES;

EID: 84895855276     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1355-x     Document Type: Article

References (53)

1. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161:505-22.
2. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives. J Control Release. 2008;125:193-209.
3. Hrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, et al. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med. 2012;4(128):128ra39.
4. Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B: Biointerfaces. 2000;18:301-13.
5. Tobio M, Gref R, Sanchez A, Langer R, Alonso MJ. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res. 1998;15:270-5.
6. Quellec P, Gref R, Dellacherie E, Sommer F, Tran MD, Alonso MJ. Protein encapsulation within poly(ethylene glycol)-coated nanospheres. II. Controlled release properties. J Biomed Mater Res. 1999;47:388-95.
7. Romberg B, Hennink WE, Storm G. Sheddable coatings for long-circulating nanoparticles. Pharm Res. 2008;25:55-71.
8. Parr MJ, Masin D, Cullis PR, Bally MB. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol). J Pharmacol Exp Ther. 1997;280:1319-27.
9. Lee Y, Koo H, Jin GW, Mo H, Cho MY, Park JY, et al. Poly(ethylene oxide sulfide): new poly(ethylene glycol) derivatives degradable in reductive conditions. Biomacromolecules. 2005;6:24-6.
10. Silvius JR, Zuckermann MJ. Interbilayer transfer of phospholipid-anchored macromolecules via monomer diffusion. Biochemistry. 1993;32:3153-61.
11. Champion JA, Katare YK, Mitragotri S. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J Control Release. 2007;121:3-9.
12. Peracchia MT, Gref R, Minamitake Y, Domb A, Lotan N, Langer R. PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics. J Control Release. 1997;46:223-31.
13. Dalhaimer P, Engler AJ, Parthasarathy R, Discher DE. Targeted worm micelles. Biomacromolecules. 2004;5:1714-9.
14. Buske J, Konig C, Bassarab S, Lamprecht A, Muhlau S, Wagner KG. Influence of PEG in PEG-PLGA microspheres on particle properties and protein release. Eur J Pharm Biopharm. 2012;81:57-63.
15. Zweers ML, Engbers GH, Grijpma DW, Feijen J. In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide). J Control Release. 2004;100:347-56.
16. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release. 2002;79:123-35.
17. Alexis F. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polym Int. 2005;54:36-46.
18. Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - a review. Int J Pharm. 2011;415:34-52.
19. Giteau A, Venier-Julienne MC, Aubert-Pouessel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm. 2008;350:14-26.
20. Ye M, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release. 2010;146:241-60.
21. Samadi N, Abbadessa A, Di Stefano A, van Nostrum CF, Vermonden T, Rahimian S, et al. The effect of lauryl capping group on protein release and degradation of poly(d, l-lactic-co-glycolic acid) particles. J Control Release. 2013;172:436-43.
22. Park TG, Yong Lee H, Sung Nam Y. A new preparation method for protein loaded poly(D, L-lactic-co-glycolic acid) microspheres and protein release mechanism study. J Control Release. 1998;55:181-91.
23. Sophocleous AM, Desai KG, Mazzara JM, Tong L, Cheng JX, Olsen KF, et al. The nature of peptide interactions with acid end-group PLGAs and facile aqueous-based microencapsulation of therapeutic peptides. J Control Release. 2013;172:662-70.
24. Ghassemi AH, van Steenbergen MJ, Talsma H, van Nostrum CF, Crommelin DJ, Hennink WE. Hydrophilic polyester microspheres: effect of molecular weight and copolymer composition on release of BSA. Pharm Res. 2010;27:2008-17.
25. Samadi N, van Nostrum CF, Vermonden T, Amidi M, Hennink WE. Mechanistic studies on the degradation and protein release characteristics of poly(lactic-co-glycolic-co-hydroxymethylglycolic acid) nanospheres. Biomacromolecules. 2013;14:1044-53.
26. Liu Y, Ghassemi AH, Hennink WE, Schwendeman SP. No acid microclimate pH in poly(D, L -lactide -co-hydroxymethyl glycolide) microspheres during biodegradation. Biomaterials. 2012;33:7584-93.
27. Ghassemi AH, van Steenbergen MJ, Barendregt A, Talsma H, Kok RJ, van Nostrum CF, et al. Controlled release of octreotide and assessment of peptide acylation from poly(D, L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres. Pharm Res. 2012;29:110-20.
28. Salmaso S, Caliceti P. Stealth properties to improve therapeutic efficacy of drug nanocarriers. J Drug Deliv. 2013;2013:374252.
29. Leemhuis M, van Nostrum CF, Kruijtzer JAW, Zhong ZY, ten Breteler MR, Dijkstra PJ, et al. Functionalized poly (alpha-hydroxy acid)s via ring-opening polymerization: toward hydrophilic polyesters with pendant hydroxyl groups. Macromolecules. 2006;39:3500-8.
30. Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ, et al. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release. 1998;50:31-40.
31. Jackson JK, Hung T, Letchford K, Burt HM. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Int J Pharm. 2007;342:6-17.
32. Beletsi A, Leontiadis L, Klepetsanis P, Ithakissios DS, Avgoustakis K. Effect of preparative variables on the properties of poly(dl-lactide-co-glycolide)-methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery. Int J Pharm. 1999;182:187-97.
33. Beletsi A, Panagi Z, Avgoustakis K. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. Int J Pharm. 2005;298:233-41.
34. Ortega-Vinuesa JL, Martín-Rodríguez A, Hidalgo-Álvarez R. Colloidal stability of polymer colloids with different interfacial properties: mechanisms. J Colloid Interface Sci. 1996;184:259-67.
35. Israelachvili JN, Mitchell DJ, Ninham BW. Theory of self-assembly of lipid bilayers and vesicles. Biochim Biophys Acta. 1977;470:185-201.
36. Blanazs A, Madsen J, Battaglia G, Ryan AJ, Armes SP. Mechanistic insights for block copolymer morphologies: how do worms form vesicles? J Am Chem Soc. 2011;133:16581-7.
37. Geng Y, Discher DE. Hydrolytic degradation of poly(ethylene oxide)-block-polycaprolactone worm micelles. J Am Chem Soc. 2005;127:12780-1.
38. Scholes PD, Coombes AG, Illum L, Davis SS, Watts JF, Ustariz C, et al. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J Control Release. 1999;59:261-78.
39. Johnstone TC, Kulak N, Pridgen EM, Farokhzad OC, Langer R, Lippard SJ. Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties. ACS Nano. 2013;7:5675-83.
40. Coombes AG, Yeh MK, Lavelle EC, Davis SS. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. J Control Release. 1998;52:311-20.
41. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82:105-14.
42. Paillard-Giteau A, Tran VT, Thomas O, Garric X, Coudane J, Marchal S, et al. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique. Eur J Pharm Biopharm. 2010;75:128-36.
43. Lee SC, Oh JT, Jang MH, Chung SI. Quantitative analysis of polyvinyl alcohol on the surface of poly(D, L-lactide-co-glycolide) microparticles prepared by solvent evaporation method: effect of particle size and PVA concentration. J Control Release. 1999;59:123-32.
44. Torche AM, Le Corre P, Albina E, Jestin A, Le Verge R. PLGA microspheres phagocytosis by pig alveolar macrophages: influence of poly(vinyl alcohol) concentration, nature of loaded-protein and copolymer nature. J Drug Target. 2000;7:343-54.
45. Zielhuis SW, Nijsen JF, Figueiredo R, Feddes B, Vredenberg AM, van het Schip AD, et al. Surface characteristics of holmium-loaded poly(L-lactic acid) microspheres. Biomaterials. 2005;26:925-32.
46. Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, et al. Polymer degradation and in vitro release of a model protein from poly(D, L-lactide-co-glycolide) nano- and microparticles. J Control Release. 2003;92:173-87.
47. Lammers T, Kiessling F, Hennink WE, Storm G. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release. 2012;161:175-87.
48. Clapper JD, Skeie JM, Mullins RF, Guymon CA. Development and characterization of photopolymerizable biodegradable materials from PEG-PLA-PEG block macromonomers. Polymer. 2007;48:6554-64.
49. Ghassemi AH, van Steenbergen MJ, Talsma H, van Nostrum CF, Jiskoot W, Crommelin DJ, et al. Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid). J Control Release. 2009;138:57-63.
50. Samadi N, Kijanka MM, Oliveira S, Vermonden T, vanden Dikkenberg JB, vanNostrum CF, et al. Nanobody-targeted and RNase-loaded nanoparticle based on a hydrophilic polyester aimed for cancer therapy. In preparation.
51. Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release. 2001;73:121-36.
52. van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res. 2000;17:1159-67.
53. Blanco D, Alonso MJ. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur J Pharm Biopharm. 1998;45:285-94.